| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.01 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.073 | 0.01 |